Pharmacy- Page 42

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Novo Nordisk increased adjusted operating profit by 8% in local currencies

The FINANCIAL -- Operating profit decreased by 3% reported in local currencies and by 6% in Danish kroner to DKK 24.8 billion. Adjusted for the non-recurring income related to the partial divestment of NNIT and the income related to out-licensing of assets

by The FINANCIAL

August 5, 2016

1 min read

Pharmacy

Teva Announces Acquisition of Anda Inc.

The FINANCIAL -- Teva Pharmaceutical Industries Ltd., on August 3 announced that it has entered into a definitive agreement to purchase Allergan’s Anda Inc., the 4th largest distributor of generic pharmaceuticals in the U.S. for $500 million.

by The FINANCIAL

August 4, 2016

1 min read

Pharmacy

Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration

The FINANCIAL -- Amgen and Advaxis, Inc. on August 2 announced a global agreement for the development and commercialization of Advaxis' ADXS-NEO, a novel, preclinical investigational cancer immunotherapy treatment that is designed to activate a patient's immune system to respond against the

by The FINANCIAL

August 2, 2016

1 min read

Pharmacy

Pfizer To Acquire Gene-Tech Company

The FINANCIAL -- Pfizer Inc. on August 1 announced that it has acquired Bamboo Therapeutics, Inc., a privately held biotechnology company based in Chapel Hill, N.C., focused on developing gene therapies for the potential treatment of patients with certain rare diseases related

by The FINANCIAL

August 2, 2016

2 mins read

Pharmacy

GSK and Verily to establish Galvani Bioelectronics

The FINANCIAL -- GSK on August 1 announced an agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, to form Galvani Bioelectronics to enable the research, development and commercialisation of bioelectronic medicines. GSK will hold a 55% equity

by The FINANCIAL

August 1, 2016

2 mins read

Pharmacy

Alcon launches Dailies Total1 Multifocal contact lenses, the first and only water gradient lenses designed for people with presbyopia

The FINANCIAL -- Alcon, one of the global leaders in eye care and a division of Novartis, introduces Dailies Total1 Multifocal contact lenses for people with presbyopia.

by The FINANCIAL

July 14, 2016

1 min read

Pharmacy

Pfizer Receives FDA Approval for Prevnar 13 in Adults Age 18 Through 49

The FINANCIAL -- Pfizer Inc. on July 12 announced that Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received U.S. Food and Drug Administration (FDA) approval for an expanded age indication to include adults 18 through 49 years of age, in

by The FINANCIAL

July 13, 2016

1 min read

Pharmacy

FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor

The FINANCIAL -- Amgen on July 11 announced that the U.S. Food and Drug Administration (FDA) has approved the Repatha (evolocumab) Pushtronex system (on-body infusor with prefilled cartridge), a new, monthly single-dose administration option.

by The FINANCIAL

July 11, 2016

1 min read

Pharmacy

Takeda Receives European Commission Approval of ADCETRIS

The FINANCIAL -- Takeda Pharmaceutical Company Limited on July 6 announced that the European Commission (EC) has extended the current conditional marketing authorization of ADCETRIS (brentuximab vedotin) and approved ADCETRIS for the treatment of adult patients with CD30+ Hodgkin lymphoma at increased

by The FINANCIAL

July 7, 2016

1 min read

Pharmacy

FDA Approves Abbott Absorbable Stent For Coronary Artery Disease

The FINANCIAL -- Abbott announced on July 5 that the U.S. Food and Drug Administration has approved the company's Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.

by The FINANCIAL

July 6, 2016

2 mins read